Hikal informs about press release

09 Nov 2022 Evaluate

Hikal has informed that it enclosed a copy of the Press Release on the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2022.

The above information is a part of company’s filings submitted to BSE.




Hikal Share Price

282.40 10.60 (3.90%)
05-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1487.45
Dr. Reddys Lab 5822.90
Cipla 1497.85
Zydus Lifesciences 1049.75
Lupin 1630.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.